Oturum Aç

Hidetaka Ohnuki

Laboratory of Cellular Oncology,
Center for Cancer Research,
National Cancer Institute,
Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute

National Institutes of Health

BIOGRAPHY

Hidetaka Ohnuki has not added Biography.

If you are Hidetaka Ohnuki and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Semaphorin 6A regulates angiogenesis by modulating VEGF signaling.

Blood Nov, 2012 | Pubmed ID: 23007403

Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression.

Cancer research Apr, 2014 | Pubmed ID: 24520074

Notch and TGFβ: Functional partners facilitating tumor progression.

Oncoimmunology , 2014 | Pubmed ID: 25114830

EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.

Nature communications Mar, 2015 | Pubmed ID: 25807892

Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling.

Science signaling Mar, 2016 | Pubmed ID: 26980441

EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta.

Scientific reports 06, 2016 | Pubmed ID: 27250641

Characterization of Semaphorin 6A-Mediated Effects on Angiogenesis Through Regulation of VEGF Signaling.

Methods in molecular biology (Clifton, N.J.) , 2017 | Pubmed ID: 27787863

Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.

Journal of the National Cancer Institute 09, 2017 | Pubmed ID: 28376153

Novel insights into endothelial cell malignancies.

Oncotarget Dec, 2018 | Pubmed ID: 30680062

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.

Cells 06, 2020 | Pubmed ID: 32629875

Iterative epigenomic analyses in the same single cell.

Genome research Oct, 2021 | Pubmed ID: 33627472

Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth.

EMBO molecular medicine 07, 2021 | Pubmed ID: 34102002

Bone marrow niches in myelodysplastic syndromes.

Journal of cancer metastasis and treatment , 2021 | Pubmed ID: 34746416

INSTITUTIONS

National Institutes of Health

JOVE ARTICLES

Reusable Single Cell for Iterative Epigenomic Analyses

Hidetaka Ohnuki¹,

David J. Venzon²,

Alexei Lobanov^3,4,

Giovanna Tosato¹

¹Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health,

²Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health,

³CCR Collaborative Bioinformatics Resource (CCBR), Center for Cancer Research, National Cancer Institute, National Institutes of Health,

⁴Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute

Genetics

Gizlilik

Kullanım Şartları

İlkeler

Bize Ulaşın

KÜTÜPHANEYE TAVSİYE ET

JoVE HABER BÜLTENLERİ

Araştırma

JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv

Eğitim

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Fakülte sitesi

Yazarlar

Genel Bakış
Yayın Süreci
Editör Kurulu
Kapsam ve İlkeler
Hakem Denetimi
SSS
Gönder

Kütüphaneciler

Genel Bakış
Görüşler | JoVE
Abonelikler
Erişim
Kaynaklar
Kütüphane Danışma Kurulu
SSS

JoVE Hakkında

Genel Bakış
Liderlik
Blog
JoVE Help Center
JoVE Sitemap

Sitemizdeki deneyiminizi iyileştirmek için çerezleri kullanıyoruz

Sitemizi kullanmaya devam ederek ya da "Devam et" butonuna tıklayarak, çerezleri kabul edebilirsiniz.

Daha fazla bilgi edin

Hidetaka Ohnuki

Laboratory of Cellular Oncology,Center for Cancer Research,National Cancer Institute,Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute

National Institutes of Health

Reusable Single Cell for Iterative Epigenomic Analyses

Laboratory of Cellular Oncology,
Center for Cancer Research,
National Cancer Institute,
Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute